Industry Trends | Insights
August 2026
Revenue cycle technology decisions are becoming harder to separate from payer behavior and regulatory change.
Healthcare organizations once evaluated revenue cycle management (RCM) platforms largely on whether they could process claims, post payments, and support routine billing workflows. Today, that is no longer enough. Payer requirements are becoming more complex, prior authorization rules are changing, interoperability expectations are expanding, and compliance requirements are increasingly embedded within everyday revenue cycle operations.
As a result, payer and regulatory changes are reshaping RCM technology decisions. Healthcare organizations increasingly need systems that can adapt as quickly as the environment around them.
Regulatory Change Is Becoming a Technology Issue
One of the clearest examples is the Centers for Medicare & Medicaid Services’ Interoperability and Prior Authorization Final Rule.
Centers for Medicare & Medicaid Services (CMS) require impacted payers to meet several operational requirements beginning in 2026, including providing specific reasons for denied prior authorization requests and meeting decision timelines of 72 hours for expedited requests and seven calendar days for standard requests. API-related requirements generally begin in 2027 and are designed to improve electronic data exchange among payers, providers, and patients (Centers for Medicare & Medicaid Services [CMS], 2024).
These requirements have direct implications for RCM technology. Revenue cycle systems increasingly need to support interoperability, electronic prior authorization, structured data exchange, and more transparent payer communication.
TIP: When evaluating RCM technology, assess whether the platform can accommodate future regulatory requirements without requiring major system redevelopment.
Payer Requirements Are Adding Another Layer of Complexity
Regulation is only part of the challenge. Commercial payers also maintain different authorization rules, medical-necessity requirements, documentation expectations, claim edits, and appeal processes.
Healthcare IT Today reports that this growing complexity is changing how organizations evaluate RCM systems. Industry leaders increasingly emphasize cloud-based and API-driven platforms, configurable payer rules, audit trails, predictive analytics, interoperability, and scalability when selecting revenue cycle technology (Miller, 2026).
The implication is significant.
A platform that performs well under today’s rules may become inefficient if every payer or regulatory change requires extensive manual reconfiguration.
RCM technology decisions therefore increasingly depend on one question:
Can the system adapt when payer and regulatory requirements change?
TIP: Avoid evaluating technology only against current workflows. Test how quickly payer rules, authorization requirements, and compliance logic can be updated.
AI and Automation Investments Are Also Being Recalibrated
The pressure to adapt is occurring while healthcare organizations continue to invest heavily in AI and automation.
HealthLeaders reports that AI and automation are expected to account for more than half of revenue cycle technology investments, while roughly three-quarters of surveyed revenue cycle leaders anticipate launching a new automation solution. Yet only 1% reported full integration of these technologies across the entire revenue cycle (Gale, 2026).
This gap matters.
Adding another automation tool does not necessarily improve RCM if the technology cannot respond to changing payer requirements, exchange information effectively with other systems, or maintain regulatory compliance.
HealthLeaders also notes that policy volatility is pushing organizations toward improved payer-provider data exchange, real-time eligibility verification, better estimate accuracy, and technologies capable of tracking rule changes (Gale, 2026).
The goal should therefore be adaptive automation, not automation for its own sake.
Interoperability Is Moving from Advantage to Requirement
Centers for Medicare and Medicaid Services (CMS) are continuing to push this direction. In 2026, the agency proposed extending electronic prior authorization requirements to prescription drugs and further incorporating HL7 FHIR standards into healthcare administrative transactions (CMS, 2026).
For healthcare organizations, this reinforces the importance of interoperability when making RCM technology decisions.
Systems increasingly need to communicate across:
- Electronic Health Record (EHR) and clinical platforms
- payer systems
- authorization workflows
- billing platforms
- patient-access tools
- analytics and reporting environments
Disconnected RCM systems can make payer and regulatory changes harder and more costly to implement.
TIP: Prioritize interoperability and configurability before adding another standalone RCM tool.
What Should Healthcare Leaders Look For?
As payer and regulatory changes continue reshaping RCM technology decisions, healthcare organizations should evaluate systems against several capabilities:
- Configurability ─ Can payer and regulatory rules be updated quickly?
- Interoperability ─ Can the system exchange data reliably across clinical, financial, and payer platforms?
- Automation with oversight ─ Can routine work be automated while exceptions remain visible to staff?
- Auditability ─ Can the organization demonstrate what happened, when, and why?
- Scalability ─ Can the platform absorb new requirements without creating additional manual workarounds?
The future of RCM technology will not be defined simply by which platform automates the most tasks.
It will be defined by which platforms can adapt fastest to payer behavior, regulatory requirements, and changing revenue-cycle priorities.
For healthcare leaders, that changes the technology question from:
“What can this system do today?”
to:
“Can this system keep up with what healthcare will require tomorrow?”
References
Centers for Medicare & Medicaid Services. (2024). CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). CMS final rule
Centers for Medicare & Medicaid Services. (2026). 2026 CMS Interoperability Standards and Prior Authorization for Drugs proposed rule. CMS proposed rule
Gale, L. (2026, January 20). Rev cycle trends to watch in 2026. HealthLeaders. HealthLeaders article
Miller, G. (2026, July 22). The influence of regulatory changes and evolving payer requirements on RCM technology strategy and system selection. Healthcare IT Today. Healthcare IT Today article
